secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 77101 grounded facts newest October 13, 2026, 6:09 AM ET RSS · JSON

Showing 301–350 of 33806

Departed

Avi Liss

Director
NCPL · Netcapital Inc.
Effective
2026-08-27
Successor
Cesar Herrera
Filed
September 3, 2026, 5:10 PM ET
On August 27, 2026, Avi Liss resigned as a member of the Board of Directors (the “Board”) of Netcapital Inc. (the “Company”), and from all committees of the Board on which he served, including the Audit Committee, effective immediately upon delivery of his written resignation to the Company.
Departed

Justin Hilty

Chief Financial Officer
PEW · GrabAGun Digital Holdings Inc.
Effective
2026-08-14
Filed
September 3, 2026, 4:54 PM ET
As previously announced, Justin Hilty resigned from his position as the Chief Financial Officer of GrabAGun Digital Holdings Inc. (the “Company”) effective August 14, 2026, and retired effective September 1, 2026.
Departed

Matt Simmons

Controller and Chief Accounting Officer
BG · Bunge Global SA
Effective
2027-03-31
Successor
Richard James
Filed
September 3, 2026, 4:02 PM ET
Matt Simmons notified the Company of his intention to retire as the Company’s Controller and Chief Accounting Officer (“CAO”) effective March 31, 2027.
Departed

Paul H. Brown

Director
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2026-09-01
Filed
September 3, 2026, 1:45 PM ET
On September 1, 2026, Paul H. Brown notified us that he will resign from the board of directors of Old Dominion Electric Cooperative, effective as of September 1, 2026.
Departed

Lisa Bollinger

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Mark C. McKenna

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Tomas Kiselak

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Jennifer Fox

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Michael Henderson

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

William (BJ) Jones

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Nimish Shah

Director
APGE · Apogee Therapeutics, Inc.
Effective
2026-09-03
Filed
September 3, 2026, 8:53 AM ET
all of the Company’s directors (Michael Henderson, M.D., Mark C. McKenna, Lisa Bollinger, M.D., Jennifer Fox, William (BJ) Jones, Jr., Tomas Kiselak and Nimish Shah) voluntarily resigned from the Company’s board of directors
Departed

Nicholas Tsahalis

Director
RLBY · RELIABILITY INC
Effective
2026-08-21
Filed
September 2, 2026, 5:30 PM ET
Mr. Tsahalis also agreed to leave the Board of Directors.
Departed

Nicholas Tsahalis

Chief Executive Officer
RLBY · RELIABILITY INC
Effective
2026-08-21
Filed
September 2, 2026, 5:30 PM ET
Mr. Nicholas Tsahalis, Chief Executive Officer of Reliability, Inc. (“Company”), responsible for The Maslow Media Group, Inc., a wholly named subsidiary of the Company, has mutually agreed to leave his position with the Company effective August 21, 2026.
Departed

Carolyn Shelton

Senior Vice President of Quality, Regulatory, and Clinical Affairs
NXL · Nexalin Technology, Inc.
Effective
2026-08-28
Filed
September 2, 2026, 4:50 PM ET
On August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc. (the “Company”).
Departed

Hugh Frater

Director
BETR · Better Home & Finance Holding Co
Filed
September 2, 2026, 4:30 PM ET
On August 27, 2026, Hugh Frater, a member of the Board of Directors (the “Board”) of Better Home & Finance Holding Company (the “Company”), informed the Company of his intention to resign from the Board in the event that Vishal Garg, the Company’s former Chief Executive Officer and a current director, assumes any executive role with the Company, including serving as a director with executive responsibilities.
Departed

James G. Pratt

Director
HTLD · HEARTLAND EXPRESS INC
Effective
2026-09-01
Filed
September 2, 2026, 1:09 PM ET
On September 1, 2026, James G. Pratt, a member of the Board of Directors (the “Board”) of Heartland Express, Inc. (the “Company”), notified the Company of his decision retire from the Board.
Departed

Randall J. Erickson

Executive Vice President, General Counsel and Corporate Secretary
ASB · ASSOCIATED BANC-CORP
Effective
2026-10-13
Filed
September 2, 2026, 10:02 AM ET
On September 2, 2026, Associated Banc-Corp (the “Company”) announced that Randall J. Erickson, age 67, Executive Vice President, General Counsel and Corporate Secretary, will retire from his position, effective October 13, 2026, after serving in the role for more than 14 years.
Departed

Vivek Jetley

President and Head of Insurance, Healthcare and Life Sciences
EXLS · ExlService Holdings, Inc.
Effective
2026-10-26
Filed
September 2, 2026, 9:58 AM ET
On August 31, 2026, Vivek Jetley, President and Head of Insurance, Healthcare and Life Sciences of ExlService Holdings, Inc. (the “Company”), notified the Company of his intention to resign from his positions with the Company, effective as of October 26, 2026.
Departed

Jason A. Amello

Chief Financial Officer
TCRX · TScan Therapeutics, Inc.
Effective
2026-09-02
Filed
September 2, 2026, 7:22 AM ET
In connection with the Strategic Reorganization, effective as of September 2, 2026 (the “Effective Date”), the employment of Jason A. Amello, the Company’s Chief Financial Officer, and Chrystal Louis, M.D., MPH, the Company’s Chief Medical Officer, was terminated.
Departed

Chrystal Louis

Chief Medical Officer
TCRX · TScan Therapeutics, Inc.
Effective
2026-09-02
Filed
September 2, 2026, 7:22 AM ET
In connection with the Strategic Reorganization, effective as of September 2, 2026 (the “Effective Date”), the employment of Jason A. Amello, the Company’s Chief Financial Officer, and Chrystal Louis, M.D., MPH, the Company’s Chief Medical Officer, was terminated.
Departed

Matthew Chretien

Chief Strategy Officer
INLX · INTELLINETICS, INC.
Effective
2026-09-01
Filed
September 2, 2026, 6:11 AM ET
On August 26, 2026, Matthew Chretien, Chief Strategy Officer of Intellinetics, Inc., a Nevada corporation (the “Company”), notified the Company that he will retire and resign his offices of Secretary and Chief Strategy Officer of the Company, effective as of September 1, 2026.
Departed (interim)

Katharyn Field

Chief Financial Officer
BRTX · BioRestorative Therapies, Inc.
Effective
2026-08-27
Successor
Anna Skowron
Filed
September 1, 2026, 6:09 PM ET
Ms. Field also ceased to serve as the Company’s interim Chief Financial Officer and Treasurer effective August 27, 2026, upon the appointment of her successor as described below
Departed (interim)

Katharyn Field

Interim Chief Executive Officer
BRTX · BioRestorative Therapies, Inc.
Effective
2026-08-26
Successor
Mika Grasso
Filed
September 1, 2026, 6:09 PM ET
On August 26, 2026, Katharyn Field advised the Board that she wished to step aside as the Company’s Interim Chief Executive Officer and Chief Financial Officer, and the Board accepted her request effective as of that date.
Departed

Katharyn Field

Director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-08-31
Filed
September 1, 2026, 6:09 PM ET
and resigned as a member of the Board effective August 31, 2026.
Departed

Alexander H. Ware

Director
BRFH · BARFRESH FOOD GROUP INC.
Effective
2026-09-15
Filed
September 1, 2026, 5:30 PM ET
On August 31, 2026, Alexander H. Ware, a member of the board of directors, notified the registrant that he would be resigning as a director effective September 15, 2026.
Departed

Lisa Roger

Chief Financial Officer
BRFH · BARFRESH FOOD GROUP INC.
Effective
2026-09-01
Successor
Delle Coste
Filed
September 1, 2026, 5:30 PM ET
On August 26, 2026, Ms. Roger advised the registrant that her last day will be September 1, 2026.
Departed

Chan Heng Fai

Chairman
HWH · HWH International Inc.
Effective
2026-09-01
Successor
Liu Ming Hui
Filed
September 1, 2026, 5:28 PM ET
On September 1, 2026, Chan Heng Fai resigned as Chairman and Chief Executive Officer of HWH International Inc. (the “Company”).
Departed

Chan Heng Fai

Chief Executive Officer
HWH · HWH International Inc.
Effective
2026-09-01
Successor
Liu Ming Xing
Filed
September 1, 2026, 5:28 PM ET
On September 1, 2026, Chan Heng Fai resigned as Chairman and Chief Executive Officer of HWH International Inc. (the “Company”).
Departed

Matthew Chretien

Chief Executive Officer
INLX · INTELLINETICS, INC.
Effective
2026-09-01
Filed
September 1, 2026, 4:45 PM ET
On August 26, 2026, Matthew Chretien, Chief Executive Officer of Intellinetics, Inc., a Nevada corporation (the “Company”), notified the Company that he will retire and resign his offices of Secretary and Chief Strategy Officer the Company, effective as of September 1, 2026.
Departed

Aaron Powell

Chief Executive Officer of the Pizza Hut business
YUM · YUM BRANDS INC
Effective
2026-09-01
Filed
September 1, 2026, 4:39 PM ET
Aaron Powell, the Chief Executive Officer of the Pizza Hut business of Yum! Brands, Inc. (the “ Company ”), resigned from his position as Pizza Hut CEO and all other positions with the Company effective September 1, 2026, in connection with the closing of the Pizza Hut Transaction (as defined below).
Departed

J. Stanley Fredrick

Chairman of the Board
MTEX · MANNATECH INC
Effective
2026-09-01
Successor
Robert Toth
Filed
September 1, 2026, 4:04 PM ET
On August 26, 2026, Mr. J. Stanley Fredrick notified the Board of Directors of Mannatech, Incorporated (the “Company”) of his intent to retire from the Board and his role as Chairman of the Board effective September 1, 2026.
Departed

Neil Salvage

Director
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
each of Bruno Bowden, Jason Mudrick, Neil Salvage, Qais Sharif and Sam Zaid, consisting of all of the members of the Company’s Board of Directors (the “Board”), has resigned from the Board
Departed

Qais Sharif

Director
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
each of Bruno Bowden, Jason Mudrick, Neil Salvage, Qais Sharif and Sam Zaid, consisting of all of the members of the Company’s Board of Directors (the “Board”), has resigned from the Board
Departed

Bruno Bowden

Director
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
each of Bruno Bowden, Jason Mudrick, Neil Salvage, Qais Sharif and Sam Zaid, consisting of all of the members of the Company’s Board of Directors (the “Board”), has resigned from the Board
Departed

Mauricio Rivera

Senior Vice President and Chief Restructuring Officer
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
the Company’s Senior Vice President and Chief Restructuring Officer, Mauricio Rivera, has resigned from his positions with the Company
Departed

Jason Mudrick

Director
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
each of Bruno Bowden, Jason Mudrick, Neil Salvage, Qais Sharif and Sam Zaid, consisting of all of the members of the Company’s Board of Directors (the “Board”), has resigned from the Board
Departed

Sam Zaid

Director
Getaround, Inc
Effective
2026-08-26
Filed
September 1, 2026, 4:02 PM ET
each of Bruno Bowden, Jason Mudrick, Neil Salvage, Qais Sharif and Sam Zaid, consisting of all of the members of the Company’s Board of Directors (the “Board”), has resigned from the Board
Departed

Sheng-Yih Chang

Co-Chief Executive Officer and Chairman of the Board
HFUS · Hartford Creative Group, Inc.
Effective
2026-09-01
Successor
Kewei Huang
Filed
September 1, 2026, 2:55 PM ET
Effective September 1, 2026, Mr. Sheng-Yih Chang resigned his position as Co-Chief Executive Officer and Chairman of the Board of the Company for health-related reasons.
Departed

Thomas J. Webb

Director
OTTR · Otter Tail Corp
Filed
September 1, 2026, 9:58 AM ET
On August 28, 2026, Thomas J. Webb notified Otter Tail Corporation (the “Company”) of his intention to not stand for reelection and instead retire from the Company’s Board of Directors effective at the conclusion of his current term, which expires at the time of the 2027 Annual Meeting of Shareholders, in accordance with the Corporation’s director retirement policy.
Departed

Kathryn O. Johnson

Director
OTTR · Otter Tail Corp
Filed
September 1, 2026, 9:58 AM ET
On August 31, 2026, Kathryn O. Johnson notified the Company of her intention to not stand for reelection and instead retire from the Company’s Board of Directors effective at the conclusion of her current term, which expires at the time of the 2027 Annual Meeting of Shareholders, having reached retirement age in accordance with the Corporation’s director retirement policy.
Departed

Rogério Vivaldi Coelho

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Caren Deardorf

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

R. Scott Struthers

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Stephanie S. Okey

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Weston Nichols

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Matthew K. Fust

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Camille L. Bedrosian

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Wendell Wierenga

Director
CRNX · Crinetics Pharmaceuticals, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 9:26 AM ET
each of the directors of the Company, R. Scott Struthers, Ph.D., Camille L. Bedrosian, M.D., Caren Deardorf, Matthew K. Fust, Weston Nichols, Ph.D., Stephanie S. Okey, M.S., Rogério Vivaldi Coelho, M.D. and Wendell Wierenga, Ph.D., resigned and ceased to be a director of the Company and a member of any committee of the Company’s Board of Directors.
Departed

Ori Lev

Executive Vice President, General Counsel and Secretary
NCSM · NCS Multistage Holdings, Inc.
Effective
2026-09-01
Filed
September 1, 2026, 8:44 AM ET
Certain officers of the Company, who resigned in their capacity as officers, but not employees, in connection with the Merger, immediately prior to the Effective Time were Ryan Hummer, Chief Executive Officer, Michael Morrison, Chief Financial Officer and Treasurer, Tim Willems, Chief Operations Officer, Ori Lev, Executive Vice President, General Counsel and Secretary and Dewayne Williams, Vice President and Controller.
Departed

Michael McShane

Director
NCSM · NCS Multistage Holdings, Inc.
Effective
2026-09-01
Successor
Beth Ann Dranguet
Filed
September 1, 2026, 8:44 AM ET
Effective as of the Effective Time, in accordance with the Merger Agreement, each member of the Company’s board of directors and certain of the Company’s officers resigned from and ceased serving on the Company’s board of directors (including any committees thereof) and as officers of the Company, as applicable.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.